These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9872535)

  • 1. Human primary Sjögren's syndrome autoantibodies as mediators of nitric oxide release coupled to lacrimal gland muscarinic acetylcholine receptors.
    Bacman SR; Berra A; Sterin-Borda L; Borda ES
    Curr Eye Res; 1998 Dec; 17(12):1135-42. PubMed ID: 9872535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjögren's syndrome.
    Bacman S; Perez Leiros C; Sterin-Borda L; Hubscher O; Arana R; Borda E
    Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):151-6. PubMed ID: 9430556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjögren syndrome.
    Bacman S; Berra A; Sterin-Borda L; Borda E
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):321-7. PubMed ID: 11157861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjögren's syndrome.
    Bacman S; Sterin-Borda L; Camusso JJ; Arana R; Hubscher O; Borda E
    Clin Exp Immunol; 1996 Jun; 104(3):454-9. PubMed ID: 9099930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-brain cholinergic auto antibodies from primary Sjögren syndrome sera modify simultaneously cerebral nitric oxide and prostaglandin biosynthesis.
    Orman B; Sterin-Borda L; De Couto Pita A; Reina S; Borda E
    Int Immunopharmacol; 2007 Dec; 7(12):1535-43. PubMed ID: 17920530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome.
    Waterman SA; Gordon TP; Rischmueller M
    Arthritis Rheum; 2000 Jul; 43(7):1647-54. PubMed ID: 10902771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Action of anti-M₃muscarinic acetylcholine receptor IgG of primary Sjögren's syndrome on the enzymatic antioxidant system in rat submandibular gland.
    Reina S; Rodríguez M; Stranieri G; Borda E
    J Oral Pathol Med; 2015 Nov; 44(10):876-83. PubMed ID: 25726719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of nitric oxide signaling through muscarinic receptors in submandibular glands by primary Sjögren syndrome antibodies.
    Pérez Leirós C; Sterin-Borda L; Hubscher O; Arana R; Borda ES
    Clin Immunol; 1999 Feb; 90(2):190-5. PubMed ID: 10080830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibitory effects of antimuscarinic autoantibodies in the sera of primary Sjogren syndrome patients on the gastrointestinal motility.
    Park K; Park S; Jackson MW
    Mol Immunol; 2013 Dec; 56(4):583-7. PubMed ID: 23911416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating antibodies against neonatal cardiac muscarinic acetylcholine receptor in patients with Sjögren's syndrome.
    Borda E; Camusso JJ; Perez Leiros C; Bacman S; Hubscher O; Arana R; Sterin-Borda L
    Mol Cell Biochem; 1996; 163-164():335-41. PubMed ID: 8974073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinergic autoantibodies from primary Sjögren's syndrome modulate submandibular gland Na+/K+-ATPase activity via prostaglandin E2 and cyclic AMP.
    Passafaro D; Reina S; Sterin-Borda L; Borda E
    Eur J Oral Sci; 2010 Apr; 118(2):131-8. PubMed ID: 20487001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sjögren autoantibodies modify neonatal cardiac function via M1 muscarinic acetylcholine receptor activation.
    Borda E; Leiros CP; Bacman S; Berra A; Sterin-Borda L
    Int J Cardiol; 1999 Jul; 70(1):23-32. PubMed ID: 10402042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human mAChR antibodies from Sjögren syndrome sera increase cerebral nitric oxide synthase activity and nitric oxide synthase mRNA level.
    Reina S; Sterin-Borda L; Orman B; Borda E
    Clin Immunol; 2004 Nov; 113(2):193-202. PubMed ID: 15451477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of autoantibodies on the muscarinic receptors in Sjögren's syndrome.
    Li J; Ha YM; Kü NY; Choi SY; Lee SJ; Oh SB; Kim JS; Lee JH; Lee EB; Song YW; Park K
    Lab Invest; 2004 Nov; 84(11):1430-8. PubMed ID: 15448705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies in primary Sjögren's syndrome patients induce internalization of muscarinic type 3 receptors.
    Jin M; Hwang SM; Davies AJ; Shin Y; Bae JS; Lee JH; Lee EB; Song YW; Park K
    Biochim Biophys Acta; 2012 Feb; 1822(2):161-7. PubMed ID: 22137887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of anti-muscarinic autoantibodies on leukocyte function in Sjögren's syndrome.
    Namkoong E; Lee SW; Kim N; Choi Y; Park K
    Mol Immunol; 2017 Oct; 90():136-142. PubMed ID: 28750255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Putative anti-muscarinic antibodies cannot be detected in patients with primary Sjogren's syndrome using conventional immunological approaches.
    Dawson LJ; Allison HE; Stanbury J; Fitzgerald D; Smith PM
    Rheumatology (Oxford); 2004 Dec; 43(12):1488-95. PubMed ID: 15353609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies against cerebral muscarinic cholinoceptors in Sjögren syndrome: functional and pathological implications.
    Reina S; Sterin-Borda L; Orman B; Borda E
    J Neuroimmunol; 2004 May; 150(1-2):107-15. PubMed ID: 15081254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies in Sjögren's syndrome patients acutely inhibit muscarinic receptor function.
    Jin M; Hwang SM; Koo NY; Kim B; Kho HS; Choi SY; Song YW; Park K
    Oral Dis; 2012 Mar; 18(2):132-9. PubMed ID: 21899666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin G from breast cancer patients in stage I stimulates muscarinic acetylcholine receptors in MCF7 cells and induces proliferation. Participation of nitric oxide synthase-derived nitric oxide.
    Negroni MP; Fiszman GL; Azar ME; Morgado CC; Español AJ; Pelegrina LT; de la Torre E; Sales ME
    J Clin Immunol; 2010 May; 30(3):474-84. PubMed ID: 20157846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.